Orthofix Medical Inc.OFIXEarnings & Financial Report
Nasdaq
OFIX Q3 2025 Key Financial Metrics
Revenue
$205.6M
Gross Profit
$148.5M
Operating Profit
$-17.0M
Net Profit
$-22.8M
Gross Margin
72.2%
Operating Margin
-8.3%
Net Margin
-11.1%
YoY Growth
4.6%
EPS
$-0.57
Financial Flow
Orthofix Medical Inc. Q3 2025 Financial Summary
Orthofix Medical Inc. reported revenue of $205.6M for Q3 2025, with a net profit of $-22.8M (-11.1% margin). Cost of goods sold was $57.1M, operating expenses totaled $165.6M.
Key Financial Metrics
| Total Revenue | $205.6M |
|---|---|
| Net Profit | $-22.8M |
| Gross Margin | 72.2% |
| Operating Margin | -8.3% |
| Report Period | Q3 2025 |
Orthofix Medical Inc. Annual Revenue by Year
Orthofix Medical Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $799.5M).
| Year | Annual Revenue |
|---|---|
| 2024 | $799.5M |
| 2023 | $746.6M |
| 2022 | $460.7M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $200.4M | $188.6M | $198.6M | $196.6M | $215.7M | $193.6M | $203.1M | $205.6M |
| YoY Growth | 64.0% | 7.7% | 6.2% | 6.8% | 7.6% | 2.7% | 2.3% | 4.6% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $925.3M | $906.0M | $882.0M | $867.9M | $893.3M | $823.1M | $837.2M | $832.6M |
| Liabilities | $326.6M | $335.7M | $336.0M | $341.9M | $390.2M | $364.9M | $378.8M | $390.1M |
| Equity | $598.7M | $570.3M | $546.0M | $525.9M | $503.1M | $458.3M | $458.3M | $442.5M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-6.7M | $-18.6M | $9.0M | $11.7M | $23.7M | $-18.4M | $11.6M | $12.4M |